Cell therapy CDMO Cellares revealed multiple technology partnerships to enhance its Cell Q platform, delivering fully automated quality control testing at commercial manufacturing scale. The platform integrates advanced liquid handling, flow cytometry, synthetic controls, and sample tracking systems developed jointly with firms such as Tecan, Cytek Biosciences, and Slingshot Biosciences. Cell Q supports streamlined, reproducible QC of up to 6,000 cell therapy batches annually, addressing challenges in scaling next-generation cell therapies. This innovation sets a new standard for automation in cell therapy quality assurance.